The global orthopedic market will exceed US $61.2 billion in revenue in 2023, per projections available in the 2019 installment of THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT®. Extremities and Sports Medicine markets are expected to post 6% to 8% year-over-year growth, with Trauma, Joint Replacement, Spine and Orthobiologics remaining in the low single digits.
Market leaders DePuy Synthes, Zimmer Biomet, Stryker, Smith & Nephew, Medtronic, Arthrex and NuVasive currently control 65% of the market, according to the report, with smaller companies continuing to gain share. All told, 1,012 companies are mentioned in the annual report, and revenue estimates are provided for companies with sales over $100 million.
The report is constructed to answer commonly-asked questions such as:
What is the market share of the top companies?
What is the revenue of the next tier of orthopedic companies, both public and private?
What new companies entered the U.S. market?
Where can I find a list of companies that play in my market?
Device companies, suppliers, consultants and analysts use the information contained within the annual report to identify acquisition targets and new customers, improve sales forecasts and business plans, and refine competitive analysis and customer dossiers.
Source: ORTHOWORLD Inc.
The global orthopedic market will exceed US $61.2 billion in revenue in 2023, per projections available in the 2019 installment of THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT®. Extremities and Sports Medicine markets are expected to post 6% to 8% year-over-year growth, with Trauma, Joint Replacement, Spine and Orthobiologics remaining in the low...
The global orthopedic market will exceed US $61.2 billion in revenue in 2023, per projections available in the 2019 installment of THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT®. Extremities and Sports Medicine markets are expected to post 6% to 8% year-over-year growth, with Trauma, Joint Replacement, Spine and Orthobiologics remaining in the low single digits.
Market leaders DePuy Synthes, Zimmer Biomet, Stryker, Smith & Nephew, Medtronic, Arthrex and NuVasive currently control 65% of the market, according to the report, with smaller companies continuing to gain share. All told, 1,012 companies are mentioned in the annual report, and revenue estimates are provided for companies with sales over $100 million.
The report is constructed to answer commonly-asked questions such as:
What is the market share of the top companies?
What is the revenue of the next tier of orthopedic companies, both public and private?
What new companies entered the U.S. market?
Where can I find a list of companies that play in my market?
Device companies, suppliers, consultants and analysts use the information contained within the annual report to identify acquisition targets and new customers, improve sales forecasts and business plans, and refine competitive analysis and customer dossiers.
Source: ORTHOWORLD Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
Copy to clipboard 
